Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis

BACKGROUND: Approximately 50% of human epidermal growth factor receptor 2 (HER2)-positive breast cancer lesions express hormone receptors. These tumors present a unique therapeutic challenge, and the optimal endocrine therapeutic approach remains controversial. We aimed to study the optimal adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Peleg Hasson, S., Brezis, M.R., Shachar, E., Shachar, S.S., Wolf, I., Sonnenblick, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988286/
https://www.ncbi.nlm.nih.gov/pubmed/33735801
http://dx.doi.org/10.1016/j.esmoop.2021.100088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988286/
https://www.ncbi.nlm.nih.gov/pubmed/33735801
http://dx.doi.org/10.1016/j.esmoop.2021.100088

Ejemplares similares